No spam - just the good stuff

Subscribe to our newsletter
Hidden
  • News
  • Investor Portal
  • Lifestyle
  • Videos

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy

InvestmentInvestor Portal

  • Investment portal
  • Investment portal login
  • Register as an investor
  • Raise finance

Lifestyle

  • Home
  • Supplements
  • Self-testing
  • Exercise
  • Nutrition
  • Tech
  • Mental wellness
  • Product reviews

More

  • Contact
  • Features

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy
Posted on November 28, 2022November 28, 2022

The importance of understanding the biological ages of different organs and systems

Biological age instead of the chronological age of different organs and systems can predict the risk of diseases for humans. …

Continue reading “The importance of understanding the biological ages of different organs and systems”

Posted on October 3, 2022October 3, 2022

Cleara Biotech closes $2.5m seed financing to advance senotherapeutics

Company set to accelerate FOXO4-therapeutics pipeline for niche-directed, anti-senescent lead candidates. Cleara Biotech, a preclinical-stage biotech focused on developing innovative, …

Continue reading “Cleara Biotech closes $2.5m seed financing to advance senotherapeutics”

Posted on July 22, 2022July 22, 2022

Can restoration of aged hematopoietic cells reverse age-related disorders?

Restoration of aged hematopoietic cells can help to improve age-related disorders, say researchers. Aging is associated with chronic diseases that …

Continue reading “Can restoration of aged hematopoietic cells reverse age-related disorders?”

Posted on April 23, 2021December 9, 2022

The Sheekey Science Show – Senolytics

This new senescence biomarker may help evaluate senolytic efficacy. Senescent cells, also known as “zombie cells”, accumulate with age. There …

Continue reading “The Sheekey Science Show – Senolytics”

Posted on April 23, 2021December 9, 2022

The Sheekey Science Show – Senolytics

This new senescence biomarker may help evaluate senolytic efficacy. Senescent cells, also known as “zombie cells”, accumulate with age. There …

Continue reading “The Sheekey Science Show – Senolytics”

Posted on April 8, 2021December 9, 2022

Juvenescence appoints Chief Scientific Officer

Innovative biotech Juvenescence has announced it has appointed Dr Grazia Piizzi as its Chief Scientific Officer. Juvenescence Ltd, a life …

Continue reading “Juvenescence appoints Chief Scientific Officer”

Posted on March 12, 2021May 12, 2022

Supplementing your longevity supplements

Professor José Viña on frailty, centenarians and why we need supplements – and why exercise is one of those longevity …

Continue reading “Supplementing your longevity supplements”

Posted on March 9, 2021December 8, 2022

Juvenescence scoops-up new longevity IP

Juvenescence CEO reveals why its deal with Portage is the smart choice for its longevity IP portfolio. Portage Biotech Inc, …

Continue reading “Juvenescence scoops-up new longevity IP”

Posted on February 23, 2021May 23, 2022

Shining a Sheekey light on science

Introducing Eleanor Sheekey and The Sheekey Science Show – taking science communication to a whole new level. The Sheekey Science Show looks …

Continue reading “Shining a Sheekey light on science”

Posts navigation

Page 1 Page 2 Next page

Find us here ...

Subscribe to our newsletter

Hidden

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy

Investment

  • Investment portal
  • Investment portal login
  • Register as an investor
  • Raise finance

Lifestyle

  • Home
  • Supplements
  • Self-testing
  • Exercise
  • Nutrition
  • Tech
  • Mental wellness
  • Product reviews

More

  • Contact
  • Features
  • Editorial Policy
  • Privacy Policy
  • Cookie Policy
  • Conditions of Business
  • Terms and Conditions
  • Copyright Policy
© Copyright 2023 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY
The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding a knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.

DISCLAIMER FOR U.S. BASED INVESTORS
The Agent of First Longevity Limited in the United States is Marco Polo Securities Inc, a non-affiliated broker-dealer registered with the US Securities and Exchange Commission. The activities of First Longevity Limited in the United States will be affected only to the extent permitted by Rule 15a-6 under the US Securities Exchange Act of 1934 and in accordance with the Services Agreement entered into between First Longevity Limited and Marco Polo Securities Inc with respect thereto. Contact at Marco Polo Securities is clientservices@mpsecurities.com; 1-347-745-6448.